Resistance to adriamycin in multicellular spheroids. 1979

R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp

UI MeSH Term Description Entries
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D008920 Misonidazole A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Ro 07-0582,Ro 7-0582,alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol,Ro 07 0582,Ro 070582,Ro 7 0582,Ro 70582
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies

Related Publications

R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
January 1998, Anticancer research,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
December 1980, British journal of cancer,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
December 2018, Journal of nanoscience and nanotechnology,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
October 1994, International journal of cancer,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
July 2009, American journal of respiratory cell and molecular biology,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
August 2003, Ai zheng = Aizheng = Chinese journal of cancer,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
February 2017, Journal of the Royal Society, Interface,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
October 1983, European journal of cancer & clinical oncology,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
January 1987, Cancer chemotherapy and pharmacology,
R M Sutherland, and H A Eddy, and B Bareham, and K Reich, and D Vanantwerp
January 2019, OncoTargets and therapy,
Copied contents to your clipboard!